Add BrightSurf on Google Email

University of Colorado Anschutz


Continuous glucose monitors help type 2 diabetes patients spend five more hours a day in healthy blood sugar range

A large-scale clinical trial found that adults using continuous glucose monitors (CGMs) spent approximately 5 additional hours each day within their target blood sugar range compared to those receiving routine care. Nearly twice as many CGM users achieved an A1c level below 7%, a common treatment goal for people with diabetes.

SourceUniversity of Colorado Anschutz·JournalNew England Journal of Medicine·DateOct 14, 2026

The University of Colorado Anschutz receives the largest federal research award in campus history, up to $120 million, to advance new treatments and diagnostics for severe hemorrhage

CU Anschutz will evaluate emerging technologies and therapeutics for severe hemorrhage, including novel blood products and diagnostic technologies. The award aims to improve care for patients experiencing severe bleeding, including trauma patients and those with postpartum hemorrhage.

Study offers new clues about how genetic risk for Alzheimer’s affects brain immune cells

A study by CU Anschutz researchers has found a possible link between the APOE4 gene, fat in the brain, and inflammation, which may help explain how genetic risk factors for Alzheimer's disease affect the brain. The study suggests that the ApoE protein can change how brain immune cells handle fat and trigger inflammation.

SourceUniversity of Colorado Anschutz·JournalAlzheimer’s & Dementia·DateOct 12, 2026

Horse-based activities may help autistic youth with behavioral and emotional challenges

A new study from CU Anschutz finds horseback riding improves hyperactivity, irritability, and emotional regulation in children with autism and psychiatric diagnoses. Horse-related activities also provide benefits for those unable to ride, enhancing communication and emotional regulation skills.

SourceUniversity of Colorado Anschutz·JournalPEDIATRICS·TypeRandomized controlled/clinical trial·DateOct 9, 2026

Study finds dementia influences decisions about life-sustaining treatment, even when advance directives request it

A study by CU Anschutz researcher found that dementia influences decisions on life-sustaining treatment, even when advance directives request it. Participants were 19 percentage points less likely to recommend life-sustaining treatment for patients with dementia than for those without, even with documented wishes calling for it.

SourceUniversity of Colorado Anschutz·JournalJAMA Network Open·DateOct 7, 2026

Scientists map the hidden protein network that helps red blood cells adapt to oxygen

Researchers identified 3,775 proteins in red blood cells and mapped thousands of physical interactions, revealing a dynamic network that adapts quickly to low-oxygen conditions. The study provides new insight into how red blood cells respond to high-altitude exposure and strenuous exercise, as well as pathological hypoxia.

SourceUniversity of Colorado Anschutz·JournalBlood·TypeExperimental study·DateSep 18, 2026

Study finds limited evidence for helping hospitalized patients with alcohol use disorder connect to follow-up care

A systematic review found that hospital-based interventions can improve connection to outpatient treatment for patients with alcohol use disorder, but the evidence is limited and uncertain. The interventions that showed promise combined behavioral strategies and care coordination with medications for AUD or social support.

SourceUniversity of Colorado Anschutz·JournalAnnals of Internal Medicine·TypeLiterature review·DateSep 8, 2026

Varicella zoster virus can cause serious disease beyond chickenpox and shingles

Researchers uncover the broad range of diseases caused by varicella zoster virus, including neurological and systemic issues, and highlight the need for better understanding and treatment of its manifestations. The virus can reactivate years after chickenpox and affect every organ, making diagnosis and treatment challenging.

SourceUniversity of Colorado Anschutz·JournalNature Reviews Disease Primers·DateSep 3, 2026

University of Colorado Anschutz researchers identify an “energy addiction” in high-risk blood cancer stem cells

Researchers at the University of Colorado Anschutz Cancer Center have identified a previously unknown metabolic weakness in high-risk myelodysplastic syndromes (MDS), a discovery that could lead to more targeted treatments for this aggressive blood cancer. The study found that high-risk MDS stem cells are unusually dependent on nicotin...

SourceUniversity of Colorado Anschutz·JournalBlood Cancer Discovery·DateAug 10, 2026

Largest real-world study finds early flu antiviral treatment reduces ICU admissions in hospitalized children

A nationwide study published in JAMA Pediatrics found that early antiviral treatment with oseltamivir reduced ICU admissions and shortened hospital stays for children hospitalized with influenza. The study of over 7,000 pediatric hospitalizations showed a 31% lower likelihood of ICU admission among treated children.

SourceUniversity of Colorado Anschutz·JournalJAMA Pediatrics·DateAug 10, 2026

Study finds many Colorado jails still lack public opioid treatment policies despite state mandate

A study by CU Anschutz researchers found that nearly 40% of Colorado's 46 county jails lacked publicly available opioid treatment policies, hindering the implementation of life-saving treatments. The lack of transparency and comprehensive policies poses significant barriers to care for incarcerated people with opioid use disorder.

SourceUniversity of Colorado Anschutz·JournalHealth & Justice·TypeData/statistical analysis·DateAug 6, 2026

Crnic Institute landmark research paves the way for personalized medicine in Down syndrome

Researchers at the University of Colorado Anschutz Linda Crnic Institute discovered unique biological processes altered among individuals with Down syndrome who have different sets of co-occurring conditions. The findings mark an important step toward personalized treatment, enabling future targeted therapies and improved health outcomes.

SourceUniversity of Colorado Anschutz·JournalNature Communications·DateJul 23, 2026

The University of Colorado Anschutz, along with UCHealth and Children’s Hospital Colorado, form strategic alliance with Bayer to advance drug development and clinical trials

The University of Colorado Anschutz, along with UCHealth and Children’s Hospital Colorado, have formed a strategic alliance with Bayer to accelerate medical discovery and expand patient access to investigational therapies. Initial focus areas include oncology, cardiovascular disease, and cell and gene therapy.

Healthy but sedentary individuals show early decline in cellular energy production

A CU Anschutz study reveals reduced mitochondrial efficiency in healthy yet sedentary individuals, which may precede the development of major diseases like cancer, diabetes, and Alzheimer's. Regular exercise acts as a literal shield for cellular health, helping mitochondria seamlessly switch between burning fat and carbohydrates.

SourceUniversity of Colorado Anschutz·JournalClinical Bioenergetics·TypeObservational study·DateJun 29, 2026

Injectable semaglutide shows early promise to improve fertility in women with PMOS

Researchers at the University of Colorado Anschutz have published a proof-of-concept study demonstrating that injectable semaglutide may offer meaningful reproductive benefits for women with PMOS, improving both reproductive and metabolic symptoms. The findings suggest that this medication could be a promising therapeutic option for wo...

SourceUniversity of Colorado Anschutz·JournalFertility and Sterility·DateJun 9, 2026

The University of Colorado Anschutz Gates Institute achieves first-in-U.S. FDA clearance for campus-built CAR T-cell therapy

The University of Colorado Anschutz Gates Institute has achieved first-in-U.S. FDA clearance for a novel CAR T-cell therapy targeting aggressive leukemia cells, representing a potential new treatment approach for patients with hard-to-treat disease. The therapy will be evaluated in a Phase 1 clinical trial starting this summer.

Researchers clarify how ketogenic diets treat epilepsy, guiding future therapy development

A new review outlines the scientific explanations behind ketogenic diets' therapeutic benefits for epilepsy, including their ability to strengthen brain energy systems, reduce inflammation, and protect neurons. The review highlights the need for further research, particularly in adults, to develop new therapies that mirror the diet's e...

SourceUniversity of Colorado Anschutz·JournalThe Lancet Neurology·DateMar 11, 2026

Why does chronic back pain make everyday sounds feel harsher? Brain imaging study points to a treatable cause

A new study from CU Anschutz links chronic back pain to heightened brain responses to everyday sounds and finds that Pain Reprocessing Therapy can improve sensory amplification. The research found specific brain changes associated with sound hypersensitivity, which can be treated with psychological therapy.

SourceUniversity of Colorado Anschutz·JournalAnnals of Neurology·DateMar 2, 2026